| The history of the Drug Utilization Research Group in Europe. | |
| | |
MedLine Citation:
|
PMID: 16329154 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Following the recommendations from a World Health Organization (WHO)/Euro symposium Consumption of drugs in 1969, a common classification system for drugs was developed, the Anatomical Therapeutic Chemical (ATC), and a technical unit of comparison, the Defined Daily Dose (DDD), as a comparative unit of drug use. This was found to be robust across therapeutic classifications, dosing forms and diverse populations. To maintain and develop the ATC/DDD system a WHO-Collaborating Centre was established in Oslo. As this was found to be of global interest the centre now reports to the WHO headquarters in Geneva. An informal WHO Drug Utilization Research Group (WHO-DURG), later the EuroDURG, has by now met 28 times in Europe. Since 1994 in Stockholm all these meetings have been with ISPE (International Society for Pharmacoepidemiology) when meeting in Europe. The main focus was initially to improve drug utilization through cross-national drug utilization studies based on the ATC/DDD methodology as they revealed large differences between and within countries that could not easily be explained by morbidity differences alone. These observed differences have led to the expansion of the area to include social, economic and qualitative methods with a more generalized public health focus. One of the most recent contributions was the development of drug use quality indicators. |
| | |
Authors:
|
Ulf Bergman |
Related Documents
:
|
19383364 - Biomarkers in oncology drug development. 22148754 - Discovery of a novel class of orally active trypanocidal n-myristoyltransferase inhibit... 20020374 - Some aspects of doping and medication control in equine sports. 20970964 - Progress report on new antiepileptic drugs: a summary of the tenth eilat conference (ei... 7902664 - Alterations in drug transport in resistant trypanosoma congolense. 3106994 - Influence of polyethylene glycol 6000 and mannitol on the in-vitro dissolution properti... |
Publication Detail:
|
Type: Historical Article; Journal Article |
Journal Detail:
|
Title: Pharmacoepidemiology and drug safety Volume: 15 ISSN: 1053-8569 ISO Abbreviation: Pharmacoepidemiol Drug Saf Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-02-07 Completed Date: 2006-08-31 Revised Date: 2009-11-03 |
Medline Journal Info:
|
Nlm Unique ID: 9208369 Medline TA: Pharmacoepidemiol Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 95-8 Citation Subset: IM |
Copyright Information:
|
Copyright 2005 John Wiley & Sons, Ltd. |
Affiliation:
|
Division of Clinical Pharmacology, Department of Laboratory Medicine, WHO Collaboration Centre for Drug Utilisation Research, Karolinska University Hospital, Huddinge, Stockholm, Sweden. Ulf.Bergman@karolinska.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Benchmarking Drug Utilization Review / history*, methods Europe Guideline Adherence History, 20th Century Humans International Cooperation Pharmaceutical Preparations / classification* Practice Guidelines as Topic Research World Health Organization |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fermentative hydrogen production and bacterial community structure in high-rate anaerobic bioreactor...
Next Document: Differential expression of protein phosphatase type 1 isotypes and nucleolin during cell cycle arres...